Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-24
2005-05-24
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S266300, C544S116000, C544S119000, C544S287000
Reexamination Certificate
active
06897213
ABSTRACT:
Novel quinazolinone derivatives with good binding affinity for the CCK-A and CCK-B receptors, pharmaceutical compositions containing them and methods of using them are taught. The compounds are useful agents to suppress appetite, reduce gastric acid secretion, and the like.
REFERENCES:
patent: 3213094 (1965-10-01), Morgan
patent: 3217005 (1965-11-01), Kirchner
patent: 3322766 (1967-05-01), Schipper
patent: 3867384 (1975-02-01), Bullock et al.
patent: 4472400 (1984-09-01), Tully et al.
patent: 4547504 (1985-10-01), Fabre et al.
patent: 4826528 (1989-05-01), Mengel et al.
patent: 5084457 (1992-01-01), Fanshawe et al.
patent: 5196427 (1993-03-01), Yu et al.
patent: 5204354 (1993-04-01), Chakravarty et al.
patent: 5276038 (1994-01-01), Takasugi et al.
patent: 5278316 (1994-01-01), Horwell et al.
patent: 5354755 (1994-10-01), Takasugi et al.
patent: 158549 (1983-01-01), None
patent: 2086903 (1981-11-01), None
patent: 9426722 (1994-11-01), None
Kottka et al., Chem. Abstract 104:207299, 1986.*
Liebowitz, PubMed Abstract (J Clin Psychiatry 58 Suppl 13:5-8), 1997.*
K. Kottke, et al.,Chemical Abstracts,1982, 96:69016j.
K. Kottke, et al.,Chemical Abstracts,1983, 99:70757v.
K. Kottke, et al.,Chemical Abstracts,1983, 99:158378h.
A.K.S. Gupta, et al.,Chemical Abstracts,1989, 111:52455g.
A-M.M.E. Omar, et al.,Eur J Med Chem—Chemica Therapeutica,1981, 16:1, 77-80.
K. Kottke, et al.,Chemical Abstracts,1983, 98:107241e.
K. Kottke, et al.,Chemical Abstracts,1978, 89:24242u.
16128u,Chemical Abstracts,vol. 78, 1973.
87715d,Chemical Abstracts,vol. 70, 1969.
140064s,Chemical Abstracts,vol. 82, 1975.
105:97416n,Chemical Abstracts,vol. 105, 1986.
96:142790p,Chemical Abstracts,vol. 96, 1982.
85:123860t,Chemical Abstracts,vol. 85, 1976.
“Intracerebroventricular Injections of Chlecystokinin Octapeptide Suppress Feeding, etc.”,Regulatory Peptides,R.R. Schick, et al, 14 (1986) 277-291.
“Antinociceptive Action of Cholecystokinin Octapeptide, etc.”,Neuropharmacology,R.G. Hill, et al, vol. 26, No. 4, pp. 289-300, 1986.
“Inhibition of Synaptic Transmission in the Hippocampus, etc.”,Brain Research,Brian A. MacVicar, et al, 406 (1987) 130-135.
“Peptides, The Limbic Lobe and Schizophrenia”, Gareth W. Roberts, et al,Brain Research,288 (1983) 199-211.
“Cholecystokinin—Immunoreactive Boutons in Synaptic Contact, etc.”, S.Totterdell and A.D. Smith,Neuroscience,vol. 19, No. 1 pp. 181-192, 1986.
“Opposite Actions of CCK-8 on Amphetamine-Induced Hyperlocomotion, etc.”, F. Weiss, et al,Pharmacology Biochemistry&Behavior,vol. 30, pp. 3098,317 (1988).
“CCK-8 Modulation of Mesolimbic Dopamine: Antagonism of Amphetamine-Stimulated Behaviors”, L.H. Schneider, et al,Peptides,vol. 4,pp. 749-753, 1983.
“Gastrointenstinal Hormones and Gastric Secrection”, S.J.Konturek,Gastrointestinal Hormones,Ch.23, pp. 529-564 (1980) ed. G.B.J. Glass, Raven Press, NY.
“Role of Gastrin and Gastrin Receptors on the Growth of a Transplantable Mouse Colon Carcinoma, etc.”,Cancer Research 44,1612-1616, Apr., 1986.
“Effects of Gastrin, Proglumide, and Somatostatin on Growth of Human Colon Cancer”,Gastroenterology1988; 95: 1541-8.
“The Physiology of Cholecystokinin in Brain and Gut”, G.J. Dockray,British Medical Bulletin(1982) vol. 38, No. 3, pp. 253-258.
“The Neuroendocrine Control of Appetite, etc.”, John E. Morley,Life Sciences,vol. 27, pp. 355-368 (1980).
“Immunochemical Evidence of Cholecystokinin Tetrapeptides in Hog Brain”, Rehfeld and Gotterman,Journal of Neurochemistry,vol. 32, pp. 1339-1341.
“Cholecystokinin Octapeptide: Continuous Picomole Injections, etc.”, Della-Fera and Baile,Science,vol. 26, pp. 471-473 (1979).
“Heterogeneity of GABAergic Cells In Cat Visual Cortex”, H.Demeulemeester, et al,The Journal of Neuroscience,Mar. 1988 (8(3):988-1000.
“Hypnotics and Sedatives”, Stewart C. Harvey,The Pharmacological Basis of Therapeutics, 1985, pp. 339-371.
“Synthesis and some reactions of 3-phenyl(1H,3H)-quinazoline-2-thione-4-one”, El-Deen and El-Desuky,J.Serb.Chem.Soc.57(11)719-723 (1992).
“Synthesis and Anticonvulsant Activity of Some New 2-Substituted 3-Aryl-4(3H)-quinazolinones”, James F. Wolfe, et alJ.Med.Chem.1990, 33, pp. 161-166.
“Synthesis of the 1,2,4-Triazolo[4,3-a] quinazol in-5-ones and Related Compounds”, H.A. El-Sherief, et alBull.Chem.Soc.Jpn., 56,1227-1230 (1983).
“Synthesis and Pesticidal Activity of some Quinazol in-4(3H)-one Derivatives,” Gupta & Pandey,Pestic.Sci.26, 1989, 41-49.
“Synthesis of some novel quinazolone thiosemicarbazide and thiazoline derivatives for potential anti-microbial activity”, Omar, et al,Eur.J.Med.Chem.—Chemica Therapeutica,Jan.-Feb., 1981-16, No. 1, pp. 77-80.
94:175041,Chemical Abstracts,vol. 94, 1981.
94:132238j,Chemical Abstracts,vol. 94, 1981.
99:158378h,Chemical Abstracts,vol. 99, 1983.
111:52455g,Chemical Abstracts,vol. 111, 1989.
89(15):1294696,Chemical Abstracts,1978.
95(1):7198r,Chemical Abstracts,1980.
98(23):198151q,Chemical Abstracts,1983.
Chemical Abstracts,Reg. No. 146849-71-0.
Chemical Abstracts,Reg. No. 121828-87-3.
Chemical Abstracts,Reg. No. 121678-90-8.
Chemical Abstracts,Reg. No. 121662-01-9.
Chemical Abstracts,Reg. No. 121662-00-8.
Chemical Abstracts,Reg. No. 121661-99-2.
Chemical Abstracts,Reg. No. 121661-98-1.
Chemical Abstracts,Reg. No. 121661-97-0.
Chemical Abstracts,Reg. No. 121661-96-9.
Chemical Abstracts,Reg. No. 121661-95-8.
Chemical Abstracts,Reg. No. 121661-94-7.
Chemical Abstracts,Reg. No. 121661-93-6.
Chemical Abstracts,Reg. No. 121661-92-5.
Chemical Abstracts,Reg. No. 121661-91-4.
Chemical Abstracts,Reg. No. 121661-90-3.
Chemical Abstracts,Reg. No. 101164-48-1.
Chemical Abstracts,Reg. No. 87466-11-3.
Chemical Abstracts,Reg. No. 87466-10-2.
Chemical Abstracts,Reg. No. 87466-09-9.
Chemical Abstracts,Reg. No. 87466-08-8.
Chemical Abstracts,Reg. No. 87466-07-7.
Chemical Abstracts,Reg. No. 87466-06-6.
Chemical Abstracts,Reg. No. 86842-56-0.
Chemical Abstracts,Reg. No. 86842-47-9.
Chemical Abstracts,Reg. No. 86662-55-7.
Chemical Abstracts,Reg. No. 86513-40-8.
Chemical Abstracts,Reg. No. 86507-00-8.
Chemical Abstracts,Reg. No. 86506-99-2.
Chemical Abstracts,Reg. No. 86506-98-1.
Chemical Abstracts,Reg. No. 86506-97-0.
Chemical Abstracts,Reg. No. 86506-96-9.
Chemical Abstracts,Reg. No. 86506-95-8.
Chemical Abstracts,Reg. No. 86506-94-7.
Chemical Abstracts,Reg. No. 85784-60-7.
Chemical Abstracts,Reg. No. 85773-55-3.
Chemical Abstracts,Reg. No. 85773-54-2.
Chemical Abstracts,Reg. No. 85773-53-1.
Chemical Abstracts,Reg. No. 85773-52-0.
Chemical Abstracts,Reg. No. 85773-51-9.
Chemical Abstracts,Reg. No. 85773-50-8.
Chemical Abstracts,Reg. No. 85773-49-5.
Chemical Abstracts,Reg. No. 85773-48-4.
Chemical Abstracts,Reg. No. 85773-47-3.
Chemical Abstracts,Reg. No. 85773-46-2.
Chemical Abstracts,Reg. No. 85773-45-1.
Chemical Abstracts,Reg. No. 85773-44-0.
Chemical Abstracts,Reg. No. 85773-43-9.
Chemical Abstracts,Reg. No. 85773-42-8.
Chemical Abstracts,Reg. No. 85773-41-7.
Chemical Abstracts,Reg. No. 85773-40-6.
Chemical Abstracts,Reg. No. 85773-39-3.
Chemical Abstracts,Reg. No. 85773-38-2.
Chemical Abstracts,Reg. No. 85773-11-1.
Chemical Abstracts,Reg. No. 85773-10-0.
Chemical Abstracts,Reg. No. 85773-09-7.
Chemical Abstracts,Reg. No. 77775-32-7.
Chemical Abstracts,Reg. No. 77747-39-8.
Chemical Abstracts,Reg. No. 77747-38-7.
Chemical Abstracts,Reg. No. 77747-37-6.
Chemical Abstracts,Reg. No. 77747-36-5.
Chemical Abstracts,Reg. No. 77437-24-2.
Chemical Abstracts,Reg. No. 77437-23-1.
Chemical Abstracts,Reg. No. 77437-22-0.
Chemical Abstracts,Reg. No. 77437-21-9.
Chemical Abstracts,Reg. No. 77437-20-8.
Chemical Abstracts,Reg. No. 77437-19-5.
Chemical Abstracts,Reg. No. 77437-18-4.
Chemical Abstracts,Reg. No. 77437-17-3.
Chemical Abstracts,Reg. No. 77437-16-2.
Chemical Abstracts,Reg. No. 77437-15-1.
Chemical Abstracts,Reg. No. 77437-14-0.
Chemical Abstracts,Reg. No.
Ashbrook Charles W.
Atkins Michael
Ganjaizadeh Mehdi
Rao Deepak
Warner-Lambert & Company
LandOfFree
Heterocycles as cholecystokinin (CCK) ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocycles as cholecystokinin (CCK) ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocycles as cholecystokinin (CCK) ligands will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3420721